Your session is about to expire
← Back to Search
Dietary Supplement
BrainPhyt High dose for Age-Associated Memory Impairment (PHAEO-FOUR Trial)
N/A
Waitlist Available
Led By Richard Kreider, PhD
Research Sponsored by Microphyt
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from week 0 to week 12
Awards & highlights
PHAEO-FOUR Trial Summary
This trial will see if BrainPhyt, a microalgae-based supplement, can help older adults with age-related memory decline improve their cognitive function.
PHAEO-FOUR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from week 0 to week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from week 0 to week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in spatial Working Memory
Secondary outcome measures
Change in attention and vigilance
Change in episodic memory
Change in executive function
+6 morePHAEO-FOUR Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BrainPhyt High doseExperimental Treatment1 Intervention
4 capsules per day containing 275mg of BrainPhyt
Group II: Placebo groupPlacebo Group1 Intervention
4 capsules per day containing 275mg of Maltodextrin
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brainphyt high dose
2022
N/A
~40
Find a Location
Who is running the clinical trial?
MicrophytLead Sponsor
4 Previous Clinical Trials
266 Total Patients Enrolled
Texas A&M UniversityOTHER
139 Previous Clinical Trials
23,875 Total Patients Enrolled
Richard Kreider, PhDPrincipal InvestigatorTexas A&M University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had or currently have any type of cancer, except for nonmelanoma skin cancer.You have had depression in the last 2 years or have taken medications for mental health within the last month.Your weight and height indicate that your body-mass index (BMI) is within a healthy range, between 18.5 and 35.0 kg/m2.You have smoked a lot, more than one pack of cigarettes per day, in the last three months.You have or had significant health problems related to your heart, kidneys, liver, hormones, lungs, digestive system, pancreas, or brain.Your high blood pressure or diabetes is not well managed or controlled.You have memory problems that are related to getting older, as defined by specific criteria set by the National Institute of Mental Health.You have struggled with alcohol or drug abuse in the past year.You have a score of 25 or higher on the MAC-Q questionnaire.You are willing to keep following your regular diet and exercise routine.You have taken any medications or supplements that can affect your ability to think clearly in the past two weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo group
- Group 2: BrainPhyt High dose
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical research accept participants of a geriatric age?
"This medical study specifies that the lower age limit for enrollment is 55, while the upper boundary stands at 65."
Answered by AI
Are there any remaining vacancies for participants in this experiment?
"Per data hosted on clinicaltrials.gov, this study is actively searching for participants. The initial posting of the trial occurred on May 1st 2022, with a recent update being made on March 7th 2023"
Answered by AI
Who fulfills the criteria for enrollment in this research project?
"Qualifying applicants should have age-associated memory impairment and be in the range of 55 to 65 years old. A total 40 people will be chosen for this clinical trial."
Answered by AI
How many participants are being admitted to this clinical research endeavor?
"Affirmative. Information available on clinicaltrials.gov suggests that recruitment for this medical study is still ongoing and began on the 1st of May 2022 with a recent edit made on 3rd July 2023. This experiment requires 40 participants from one centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger